On 1st – 2nd of June, VitaVitro Biotech passed the ISO 13485 Microbial Special Audit of British Standards Institute (BSI)with zero defects.
Microbiological Special Audit is one of important parts of ISO 13485 quality management system audit. According to the requirements of ISO 13485 and relevant standards such as packaging, sterilization and simulated transportation, BSI experts comprehensively reviewed the microbial control system of VitaVitro Biotech, including production site audit, microbial laboratory site audit and document audit.
Since our foundation on 2015, the company has started to build a high-level microbial control system to ensure the output of high-quality products, and constantly improve and perfect in the development process. The perfect result of this microbiological audit is a high recognition of our previous work and a milestone in the development of VitaVitro quality management system.
VitaVitro Biotech will continue to adhere to the concept of "Quality, Regulations, Innovation, and Dedication", take the zero defect audit results as an opportunity to move towards a more perfect quality management level, speak with product quality, and strive to a widely brand recognition worldwide.